BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38348790)

  • 1. Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.
    Chen Y; Sun L; Li L
    J Obstet Gynaecol; 2024 Dec; 44(1):2311658. PubMed ID: 38348790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Hu J; Liao D; Sun Z; Ren W; Zhao L; Fang Y; Hu K; Yu H; Liu S; Zhou L; He T; Zhang Y
    Carcinogenesis; 2023 May; 44(3):221-231. PubMed ID: 36847693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.
    Xia YF; Pei GH; Wang N; Che YC; Yu FS; Yin FF; Liu HX; Luo B; Wang YK
    Virol J; 2017 Feb; 14(1):20. PubMed ID: 28160779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
    Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.
    Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J
    Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
    Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
    Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of Lonicera japonica-derived exosomal miR2911 on human papilloma virus.
    Chi Y; Shi L; Lu S; Cui H; Zha W; Shan L; Shen Y
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116969. PubMed ID: 37516391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.
    Honegger A; Schilling D; Bastian S; Sponagel J; Kuryshev V; Sültmann H; Scheffner M; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS Pathog; 2015 Mar; 11(3):e1004712. PubMed ID: 25760330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Zhang J; Yu X; Guo Y; Wang D
    Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV E7 affects the function of cervical cancer cells via the TAL1/lnc‑EBIC/KLHDC7B axis.
    Wang J; Xiang F; Liu X; Ma X; Cai X; Yang Y; Shen X; Yuan C; Xiang Y; Xiao H
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p/suppressor of zeste 12 pathway.
    Liu J; Zhao H; Zhang Q; Shi Z; Zhang Y; Zhao L; Ren Y; Ou R; Xu Y
    Exp Cell Res; 2020 Nov; 396(1):112277. PubMed ID: 32918895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
    Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
    Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
    Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
    Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
    Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.